Testicles protect viruses from immune attack, foiling attempts to destroy the pathogens
Drugs modified by chemistry Nobel laureate Ben Feringa can be turned on and off by light, which could help keep bacteria from developing antibiotic resistance.
Novartis’s retiring CEO hopes such treatments will soon be deployed against lymphoma, other cancers
Researchers found a sixfold increase in heart attacks in patients in the week following a flu. Christopher Intagliata reports.
Researchers hope their new approach, which works well in lab animals, may save more lives
An algorithm originally designed to help robots move was useful in tackling an entirely different problem
Drugs that disrupt production of toxic proteins in the brain could work for various degenerative disorders, including Alzheimer’s and Parkinson’s
Many new drugs trigger an immune reaction that cripples them—and the race is on to thwart the attack
The former pharmaceutical executive said tackling the opioid crisis will be another priority
This gene therapy for vision loss will initially cost $850,000
An early experiment demonstrates the shutting down of a faulty gene
New filings show that there was record spending last year
The three-year-old policy had “paused” 21 publicly-funded projects
A flash of radiation drastically reduced arrhythmia in a small group of patients, for at least a year after treatment. Christopher Intagliata reports.
The report comes from the Food and Drug Administration
Hospitals consistently score low on quietness surveys. An acoustician suggests a few ways hospitals could keep the peace and quiet. Christopher Intagliata reports.
French drug company Sanofi announced that the inoculation could sometimes worsen the disease
Medications can change body chemistry to make it more hospitable to invading microbes
3-D printed gel contains bacteria that produce compounds for medicine or pollution cleanup
Scientists hope to test experimental therapies on these “micro-brains”